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Dr Eugene M. Langan, III (Greenville, SC). Dr Stanley and
Colleagues from the University of Texas Southwestern present an
interesting study on patients with type B aortic dissections treated
with TEVAR that underwent volumetric analysis. Their premise is
that false lumen thrombosis is a key to successful long term
outcomes. They treated 31 patients over 50 months and have
follow-up imaging on 23 patients or 74%. The majority of the
patients treated with TEVAR were treated for chronic indications.
False lumen thrombosis was achieved in 13 of 23 patients or 57%.
Patients with false lumen thrombosis had statistically significant
increased TLVi and decreased FLVi. There was one mortality and
8 patients or 35% required re-intervention with no difference
between the two study groups.
This is an appealing study and the most important fact that I
take away is that there is increased false lumen thrombosis on the
patients treated with TEVAR when the aneurysm is approximately
5 cm or less. This could influence decision making during the
follow-up phase of patients with type B aortic dissections being
treated medically.
I have three questions for the authors:
1. In the manuscript you suggest early intervention with
TEVAR on patients that present with type B aortic dissection
and infer with or without complications. Yet you reference the
INSTEAD study that show only 20.6% of patients treated
medically come to either open or endo repair. Then you push
for early repair on patients that may be difficult, or lost to
follow-up when you have incomplete imaging on 26% of your
patients. With these facts and a complication/re-intervention
rate of 35% would it not be better to medically these patients
and follow them and intervene before they enlarge to a diameter
 5 cm as suggested by your findings?
2. You show that false lumen thrombosis is a key to better long
term outcomes, was there any attempt to cover both proximal
and distal entry and re-entry points when possible?
3. Our data has shown that when following patients long term
with type B aortic dissections there is an increasedmortality rate
unrelated to the dissection suggesting this is a systemic condi-
tion with poor prognostic indications. Although your average
follow-up was only 9 months do you think these patients are
indeed sicker and may have increased mortality?Dr Gregory A. Stanley. Thank you, Dr Langan, for your
omments and questions. In response to your first question, the
esults of the INSTEAD study include data for a follow-up period
f 24 months, and as such, may not be telling the whole story.
ates of conversion to open or endovascular intervention in med-
cally treated patients is as high as 40% in some studies, so the mid-
nd long-term surgical intervention rates of the INSTEAD trial
ay shed more light on the natural history of this disease with
urrent management strategies. Many of our patients receive pre-
nd post-operative imaging and follow-up at outside facilities
ithin our referral area, which accounts for our lower inclusion
ercentage due to lack of imaging. I would still favor early inter-
ention before aneurysmal dilatation, especially in patients at high
isk of being lost to follow-up, because our ability to induce false
umen thrombosis with TEVAR is limited with increasing diameter
nd size of the aorta. Our data suggests that the mean diameter of
-cm is still amenable to inducing false lumen thrombosis and may
e a good benchmark for intervention. Requiring more secondary
rocedures after TEVAR would not deter me knowing that false
umen thrombosis, and thus a better outcome, is achievable.
To answer your second question, we attempt to cover as many
enestrations as possible in the thoracic aorta, but coverage of the
roximal entry tear is our ultimate goal. All of these patients have
ultiple septal fenestrations along the length of the dissection, and
ften distal re-entry points are in the abdominal aorta that are not
menable to coverage. Interestingly, only four patients in our study
ad complete false lumen thrombosis including the distal dissec-
ion, so the majority have retrograde filling distal to the stent graft
nd that remains to be a risk factor for long-term complications.
Finally, I agree with the theory that this is a systemic condi-
ion, and that these patients have a poorer prognosis overall. I
uestion whether the dissection is a marker of an underlying
ystemic condition or if the dissection adds an inflammatory me-
iator leading to future systemic problems and perhaps mortality.
n either case, we know that false lumen thrombosis is associated
ith better outcomes, and we are only now beginning to under-
tand the factors that will reliably predict who will achieve that
esult after TEVAR. The data in this study shows that if you can
ignificantly increase the volume percent of the true lumen relative
o the total size of the aorta, post-operative false lumen thrombosis
an be consistently expected.
